New York, NY, United States of America

Ramon Mohanlal

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Ramon Mohanlal: Innovator in Neutropenia Research

Introduction

Ramon Mohanlal is a prominent inventor based in New York, NY (US), known for his significant contributions to medical research, particularly in the field of neutropenia. With a total of 8 patents to his name, he has made strides in developing methods and compositions aimed at improving patient outcomes.

Latest Patents

Among his latest patents is a method of stimulating neutrophil survival and reducing neutropenia. This patent discloses the use of plinabulin for reducing neutropenia, particularly in cases induced by docetaxel. Another notable patent focuses on a composition and method for reducing neutropenia caused by chemotherapy or radiation therapy through the administration of plinabulin to a subject.

Career Highlights

Ramon has worked with Beyondspring Pharmaceuticals, Inc., where he has played a crucial role in advancing research and development in his field. His work has been instrumental in addressing the challenges faced by patients undergoing chemotherapy and radiation therapy.

Collaborations

Throughout his career, Ramon has collaborated with notable colleagues, including Lan Huang and George Kenneth Lloyd. These partnerships have contributed to the innovative research and development efforts in the medical field.

Conclusion

Ramon Mohanlal's work in neutropenia research exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to improving patient care and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…